Pharmazz EU Limited
- Address
- The Black Church, Saint Mary's Place North
Sponsor Overview
Specializations
Neurology and Stroke
Pharmazz EU Limited is active in acute cerebral ischemic stroke, with research centered on recovery after an acute brain ischemic event and functional outcomes measured in the post-stroke period.
- Acute cerebral ischemic stroke
- Neurological recovery
- Functional outcome assessment
The sponsor’s clinical interest in this area is focused on improving patient function after stroke, including outcomes captured through the modified Rankin Scale.
Cerebrovascular and Brain Ischemia
Its trial activity reflects a therapeutic focus on cerebrovascular disease, particularly the management of brain ischemia and the medical consequences of reduced blood flow to the brain.
- Cerebrovascular injury
- Ischemic brain damage
- Post-ischemic neurological impairment
This area of interest aligns with efforts to address disability and recovery challenges following ischemic stroke.
Acute Neurological Care
The sponsor’s research landscape includes treatment of patients in the acute phase of stroke, where rapid neurological intervention and early outcome evaluation are central concerns.
- Acute stroke management
- Early functional recovery
- Neurological disability
Its clinical work in this field is directed toward patient-centered endpoints that reflect independence and daily functioning after the initial stroke event.
Neurotherapeutics
Pharmazz EU Limited supports research into therapeutic approaches for central nervous system injury, with attention to interventions intended to improve outcomes in stroke rehabilitation and recovery.
- Neuroprotective therapy
- Stroke recovery
- Central nervous system injury
The sponsor’s funded trial activity is concentrated on a single neurological indication, reflecting a focused interest in therapies for post-stroke functional improvement.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Sovateltide Efficacy and Safety in Acute Cerebral Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial |  Germany Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 29 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
29 centres- Address
- Eissendorfer Pferdeweg 52, Heimfeld, 21075 Hamburg
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Avenida Del Rey Juan Carlos I 00002, 52001 Melilla
- Address
- Paseo De La Castellana 261, 28046 Madrid
- Address
- Calle Del Profesor Martin Lagos Sn, 28040 Madrid
- Address
- Calle Hermanos Falco 37, 02006 Albacete
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Pharmazz EU Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.